Oral anticoagulant treatment in very elderly patients with atrial fibrillation.
Many factors can influence the final decision to treat nonrheumatic atrial fibrillation in the very elderly patient with anticoagulants. Therefore, a systemic approach in which the thromboembolic and hemorrhagic risk profiles are taken into account is suggested.
Department of Clinical and Experimental Medicine, Thrombosis Center, University of Padova School of Medicine, Ex Busonera Hospital, via Gattamelata, 64 I-35128 Padova, Italy.
V
V
Pengo
D000284:Administration, Oral; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D005853:Geriatrics; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin